- Federal judge agrees with ObamaCare supporters – mere thoughts and inaction constitute interstate commerce (Blog of Legal Times; Cato@Liberty)
- Creative class action plaintiffs’ lawyering takes two more hits in the federal courts (Consumer Class Actions & Mass Torts – here and here)
- Broader ramifications of the Supreme Court’s Brusewitz ruling (Drug & Device Law)
- Can and should the federal government be in the business of new drug innovation? (Drug Wonks)
- What can be concluded from the past year’s enforcement of the Foreign Corrupt Practices Act? (FCPA Prof)
- Is Texas’s antitrust investigation of Google appropriate, or Quixotic? (Regulation 2.0)
- Assessment of SCOTUS argument in Global Tech patent case (SCOTUSblog)
- Fraudulent fen-phen drug class action litigation may lead to disbarment for one infamously legendary plaintiffs’ lawyer (WSJ Law Blog)
